23andMe Inc. (ME): Bathi sing dikarepake

23andMe Inc. (ME) - logo korporat

Risks for 23andMe Holding Co. (ME) are mitigated by a combination of B2C test sales and B2B partnerships with pharma giants. The forward earnings indicator visualizes these processes, where the value of expresses the metric level. Moderate biotech sector cyclicity and long drug development cycles provide stability. Growth potential is embedded in the transition to AI analytics and paid subscriptions for genetic reports.

ME: Prakiraan bathi perusahaan 23andMe Holding Co. 04.07.2022 - 18.11.2026

Rincian analitis perusahaan 23andMe Holding Co.

Analisis dhasar perusahaan:ME, 23andMe Inc.
Barang utama 23andMe Holding Co

The monetization of the largest genetic data archive of 23andMe Holding Co. (ME) transforms static information into a long-term asset for medicine. The current calculated level of reflects the market valuation of this database's ability to generate cash flow. This metric aggregates consensus net income forecasts, separating speculative noise from fundamental value. The indicator's growth confirms the capitalization of intellectual property. By analyzing the expected earnings growth, an investor determines the risk of overpaying for the asset.

Perusahaan pesaing

Bathi sing dikarepake Agilent Technologies, Inc.|Bathi sing dikarepake DGX|Bathi sing dikarepake Illumina Corp (ILMN)|Bathi sing dikarepake EXAS (Exact Sciences)|Revvity Inc - Bathi mangsa ngarep|Prakiraan bathi perusahaan Bio-Rad Laboratories (BIO)|NNNN - Bathi sing dikarepake|Prakiraan bathi perusahaan Sotera Health Corp SHC|QDEL: Proyeksi bathi mangsa ngarep|OPK - Prakiraan bathi perusahaan|Bathi sing dikarepake CareDx|maravai.com (MRVI) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep FLGT|Bathi resik mangsa ngarep LAB|cytekbio.com - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSUR|exagen.com - Proyeksi bathi mangsa ngarep|MDXH (MDxHealth SA) - Prakiraan bathi resik|LUCD: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Prenetics Global (PRE)|IMDX (Insight Molecular Diagnostics) - Proyeksi bathi mangsa ngarep|Trinity Biotech (TRIB) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep PRPH|AIMD (Ainos, Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CODX (codiagnostics.com)|Bathi resik mangsa ngarep HSCS (HeartSciences)|Biomerica Inc - Proyeksi bathi mangsa ngarep|CDIO (cardiodiagnosticsinc.com) - Prakiraan bathi resik|ONCO (Onconetix) - Bathi mangsa ngarep|Bathi resik sing dikarepake viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aspira Women's Health, Inc. AWH|Bathi mangsa ngarep AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Prakiraan bathi resik|Enzo Biochem, Inc. - Bathi mangsa ngarep|FRES - Bathi mangsa ngarep|GENE - Bathi sing dikarepake|Psychemedics Corporation (PMD) - Bathi mangsa ngarep